Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Change in Accured Expenses (2016 - 2025)

Iradimed (IRMD) has disclosed Change in Accured Expenses for 13 consecutive years, with -$150000.0 as the latest value for Q1 2025.

  • Quarterly Change in Accured Expenses rose 76.22% to -$150000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$150000.0 through Dec 2025, down 115.05% year-over-year, with the annual reading at -$150000.0 for FY2025, 115.05% down from the prior year.
  • Change in Accured Expenses for Q1 2025 was -$150000.0 at Iradimed, down from $487877.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $831699.0 in Q4 2023, with the low at -$789247.0 in Q2 2023.
  • Average Change in Accured Expenses over 5 years is $132594.6, with a median of $250000.0 recorded in 2023.
  • The sharpest move saw Change in Accured Expenses soared 3227.35% in 2023, then tumbled 352.35% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $400574.0 in 2021, then crashed by 83.31% to $66838.0 in 2022, then skyrocketed by 1144.35% to $831699.0 in 2023, then plummeted by 41.34% to $487877.0 in 2024, then crashed by 130.75% to -$150000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$150000.0, $487877.0, and $379527.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.